Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Operating Expenses | 9,275 | 6,970 | 7,282 | 6,480 | 5,956 |
| Operating Income | -9,275 | -6,970 | -7,282 | -6,480 | -5,956 |
| Interest Expense | 1,868 | 1,592 | 2,128 | 1,166 | 654 |
| Other Income | 20,907 | 5,640 | 206 | -2,078 | -23,133 |
| Pre-tax Income | 9,764 | -2,922 | -9,204 | -9,724 | -29,743 |
| Income Tax | 4 | 12 | -1 | 20 | N/A |
| Net Income Continuous | 9,760 | -2,934 | -9,203 | -9,744 | -29,743 |
| Net Income | $9,768 | $-2,934 | $-9,203 | $-9,744 | $-29,743 |
| EPS Basic Total Ops | 9.44 | -3.20 | -28.64 | -10.88 | -39.20 |
| EPS Basic Continuous Ops | 10.70 | -3.24 | -28.55 | -10.95 | -39.15 |
| EPS Diluted Total Ops | -9.28 | -3.20 | -28.64 | -10.88 | -39.20 |
| EPS Diluted Continuous Ops | 10.12 | -3.24 | -28.55 | -10.95 | -39.15 |
| EBITDA(a) | $-8,853 | $-6,502 | $-6,784 | $-5,979 | $-5,459 |